Looks like the Astra Zanica / Oxford trial is back on track, and still set for a January roll out date, possibly. This will help.

Key points:

• Globally some 18,000 people have received the trial vaccine
• The vaccine was in late-stage clinical trials in the US, Britain, Brazil and South Africa
• The US was aiming for fast-track approval of a vaccine before November's presidential election.

Oxford and AstraZeneca resume UK coronavirus vaccine trial

Oxford University has announced it will resume a trial for a coronavirus vaccine it is developing with pharmaceutical company AstraZeneca after getting the green light from safety watchdogs.

In a statement, the university confirmed the restart across all of its UK clinical trial sites.The late-stage trials of the experimental vaccine were suspended last week following a reported side-effect in a UK patient.

The patient involved in the study had been reportedly suffering from neurological symptoms associated with a rare spinal inflammatory disorder called transverse myelitis.

The vaccine being developed by Oxford and AstraZeneca has been widely perceived to be one of the strongest contenders among the dozens of coronavirus vaccines in various stages of testing around the world.

Last month, the Australian Government signed an agreement with AstraZeneca to secure the potential COVID-19 vaccine, if its trials proved successful.

Prime Minister Scott Morrison said if the vaccine succeeded, the Government would manufacture it immediately and make it free for all Australians.

https://www.abc.net.au/news/2020-09-13/astrazeneca-oxford-university-resume-coronavirus-vaccine-trial/12658984